ALLO
Price
$2.77
Change
-$0.24 (-7.97%)
Updated
May 17, 6:59 PM EST
80 days until earnings call
RCUS
Price
$16.90
Change
-$0.54 (-3.10%)
Updated
May 17, 6:59 PM EST
73 days until earnings call
Ad is loading...

ALLO vs RCUS

Header iconALLO vs RCUS Comparison
Open Charts ALLO vs RCUSBanner chart's image
Allogene Therapeutics
Price$2.77
Change-$0.24 (-7.97%)
Volume$1.68M
CapitalizationN/A
Arcus Biosciences
Price$16.90
Change-$0.54 (-3.10%)
Volume$106.13K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs RCUS Comparison Chart

Loading...

ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
RCUSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLO vs. RCUS commentary
May 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Sell and RCUS is a StrongSell.

COMPARISON
Comparison
May 20, 2024
Stock price -- (ALLO: $2.77 vs. RCUS: $16.90)
Brand notoriety: ALLO and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 111% vs. RCUS: 83%
Market capitalization -- ALLO: $473.26M vs. RCUS: $1.54B
ALLO [@Biotechnology] is valued at $473.26M. RCUS’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while RCUS’s TA Score has 6 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 3 bearish.
  • RCUS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ALLO and RCUS are a good buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а +0.36% price change this week, while RCUS (@Biotechnology) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 07, 2024.

RCUS is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for RCUS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RCUS($1.54B) has a higher market cap than ALLO($473M). RCUS YTD gains are higher at: -11.518 vs. ALLO (-13.707).
ALLORCUSALLO / RCUS
Capitalization473M1.54B31%
EBITDAN/AN/A-
Gain YTD-13.707-11.518119%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLORCUS
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
RCUSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLPIX35.670.25
+0.71%
Goldman Sachs MLP Energy Infras Inv
ADGZX25.310.06
+0.24%
AB Core Opportunities Z
HAREX72.14N/A
N/A
Carillon Eagle Mid Cap Growth R3
ASRCX8.11N/A
N/A
Invesco Global Real Estate Income C
RESGX16.87-0.01
-0.06%
Glenmede Responsible ESG US Equity

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ITOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-3.21%
ITOS - RCUS
54%
Loosely correlated
+0.84%
NTLA - RCUS
46%
Loosely correlated
+0.19%
VSTM - RCUS
45%
Loosely correlated
-5.19%
AGIO - RCUS
43%
Loosely correlated
-1.89%
ALLO - RCUS
42%
Loosely correlated
-7.97%
More